Skip to main content

Page of 3
and
  1. Article

    Open Access

    Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance

    The advent of immune checkpoint inhibitors (ICIs) caused a paradigm shift both in drug development and clinical practice; however, by virtue of their mechanism of action, the excessively activated immune syste...

    Emanuel Raschi, Milo Gatti, Francesco Gelsomino, Andrea Ardizzoni in Targeted Oncology (2020)

  2. No Access

    Article

    Signal of potentially protective drug–drug interactions from spontaneous reporting systems: proceed with caution

    Ippazio Cosimo Antonazzo, Elisabetta Poluzzi, Emanuele Forcesi in Acta Diabetologica (2020)

  3. No Access

    Article

    Myopathy with DPP-4 inhibitors and statins in the real world: investigating the likelihood of drug–drug interactions through the FDA adverse event reporting system

    To investigate the occurrence of myopathy with oral glucose-lowering drugs (OGLDs) and statins, with a focus on dipeptidyl peptidase-4 inhibitors (DPP4-is).

    Ippazio Cosimo Antonazzo, Elisabetta Poluzzi, Emanuele Forcesi in Acta Diabetologica (2020)

  4. No Access

    Article

    Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System

    Immune checkpoint inhibitors (ICIs), including antibodies targeting cytotoxic T-lymphocyte associated protein 4 (CTLA4) and programmed cell death 1 or its ligand (PD1/PDL1), elicit different immune-related adv...

    Emanuel Raschi, Alessandra Mazzarella, Ippazio Cosimo Antonazzo in Targeted Oncology (2019)

  5. Article

    The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand?

    Enormous progress has been made globally in the use of evidence derived from patients’ clinical information as they access their routine medical care. The value of real-world data lies in their complementary n...

    Gianluca Trifirò, Rosa Gini, Francesco Barone-Adesi, Ettore Beghi in Drug Safety (2019)

  6. Article

    Open Access

    Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas

    The incretin-based medicines GLP1 analogues (GLP1a) and dipeptidyl peptidase-4 inhibitors (DPP4i) are hypoglycaemic agents licensed for the treatment of type 2 diabetes mellitus (T2DM). Although these drugs po...

    Giuseppe Roberto, Francesco Barone-Adesi, Francesco Giorgianni in BMC Endocrine Disorders (2019)

  7. No Access

    Article

    Adverse Events to Food Supplements Containing Red Yeast Rice: Comparative Analysis of FAERS and CAERS Reporting Systems

    Food supplements containing red yeast rice (RYR) are proposed as an alternative in statin-intolerant patients, although they actually contain natural statin(s) and their safety in clinical practice is still in...

    Emanuel Raschi, Anna Girardi, Elisabetta Poluzzi, Emanuele Forcesi in Drug Safety (2018)

  8. Article

    Open Access

    Recurrence of pericarditis after influenza vaccination: a case report and review of the literature

    This case report describes a patient with pericarditis likely attributed to influenza vaccination (positive rechallenge), with a literature review.

    Riccardo Mei, Emanuel Raschi, Elisabetta Poluzzi in BMC Pharmacology and Toxicology (2018)

  9. No Access

    Article

    Use of antihistamines and risk of ventricular tachyarrhythmia: a nested case-control study in five European countries from the ARITMO project

    After regulatory restrictions for terfenadine and astemizole in ‘90s, only scarce evidence on proarrhythmic potential of antihistamines has been published. We evaluate the risk of ventricular tachyarrhythmia (...

    Elisabetta Poluzzi, I. Diemberger in European Journal of Clinical Pharmacology (2017)

  10. No Access

    Article

    Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Map**

    The role of drugs in the occurrence of multiple sclerosis (MS) is perceived to be insufficiently investigated.

    Ippazio Cosimo Antonazzo, Emanuel Raschi, Luca Vignatelli, Elisa Baldin in Drug Safety (2017)

  11. No Access

    Article

    Drug-Induced Arrhythmia: Bridging the Gap Between Pathophysiological Knowledge and Clinical Practice

    Elisabetta Poluzzi, Emanuel Raschi, Igor Diemberger, Fabrizio De Ponti in Drug Safety (2017)

  12. No Access

    Article

    Authors’ Reply to Alain Braillon’s Comment on “The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project”

    Emanuel Raschi, Elisabetta Poluzzi, Francesco Salvo, Ugo Moretti in Drug Safety (2016)

  13. No Access

    Article

    Response to comment on: “antibiotic use varies substantially among adults—a cross‑national study from five European Countries in the ARITMO project”

    Anil Mor, Reimar Wernich Thomsen, Trine Frøslev, Edeltraut Garbe in Infection (2016)

  14. Article

    Erratum to: Antibiotic use varies substantially among adults: a cross-national study from five European Countries in the ARITMO project

    Anil Mor, Trine Frøslev, Reimar Wernich Thomsen, Alessandro Oteri in Infection (2016)

  15. Article

    Open Access

    The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project

    Spontaneous reporting systems (SRSs) are pivotal for signal detection, especially for rare events with a high drug-attributable component, such as torsade de pointes (TdP). Use of different national SRSs is ra...

    Emanuel Raschi, Elisabetta Poluzzi, Francesco Salvo, Ariola Koci in Drug Safety (2016)

  16. No Access

    Article

    Trends in paediatric macrolide use in five European countries—a population-based study

    The study aims to analyse overall as well as subgroup-specific outpatient paediatric macrolide use in five European countries, including time trends of macrolide prescription rates, and to provide potential ta...

    Jakob Holstiege, Dirk Enders, Tania Schink in European Journal of Clinical Pharmacology (2015)

  17. No Access

    Article

    Antibiotic use varies substantially among adults: a cross-national study from five European Countries in the ARITMO project

    To examine patterns of outpatient and community antibiotic use among adults in five European countries.

    Anil Mor, Trine Frøslev, Reimar Wernich Thomsen, Alessandro Oteri in Infection (2015)

  18. Article

    Open Access

    Drug-Induced Renal Damage in Preterm Neonates: State of the Art and Methods for Early Detection

    Only a small fraction of drugs widely used in neonatal intensive care units (NICU) are specifically authorized for this population. Even if unlicensed or off-label use is necessary, it is associated with incre...

    Anna Girardi, Emanuel Raschi, Silvia Galletti, Elisabetta Poluzzi in Drug Safety (2015)

  19. No Access

    Article

    Comment on: “Pharmacokinetics in Patients with Chronic Liver Disease and Hepatic Safety of Incretin-Based Therapies for the Management of Type 2 Diabetes Mellitus”

    Emanuel Raschi, Elisabetta Poluzzi, Fabrizio De Ponti in Clinical Pharmacokinetics (2015)

  20. Article

    Open Access

    Use of phytoestrogens and effects perceived by postmenopausal women: result of a questionnaire-based survey

    Use of food supplements-containing phytoestrogens among postmenopausal women is rapidly increasing. Although phytoestrogens are often perceived as safe, evidence for overall positive risk-benefit profile is st...

    Anna Girardi, Carlo Piccinni, Emanuel Raschi in BMC Complementary and Alternative Medicine (2014)

Page of 3